Ines Zidi researcher
Zidi, Inès 1978-
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 190771843 (Personal)
Permalink: http://viaf.org/viaf/190771843
Preferred Forms
-
100 0 _
‡a
Ines Zidi
‡c
researcher
-
100 1 _
‡a
Zidi, Inès,
‡d
1978-....
-
100 1 _
‡a
Zidi, Inès
‡d
1978-
4xx's: Alternate Name Forms (1)
Works
| Title | Sources |
|---|---|
| Association of lymphotoxin alpha polymorphism with type 1 diabetes in a Tunisian population. |
|
| Fungal Community Investigation from Propolis Natural Products: Diversity and Antibacterial Activities Evaluation |
|
| Golimumab and malignancies: true or false association? |
|
| HLA-G as predisposing for metastasis. |
|
| HLA-G, HLA-E, and IDO overexpression predicts a worse survival of Tunisian patients with vulvar squamous cell carcinoma |
|
| Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. |
|
| Hypoxia modulates HLA-G gene expression in tumor cells. |
|
| Importance of HLA-G in therapy of cancer |
|
| Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers. |
|
| Increased levels of soluble HLA-G molecules in Tunisian patients with chronic hepatitis B infection |
|
| Nanoparticles targeting HLA-G for gene therapy in cancer. |
|
| NF-kappa B is involved in the regulation of HLA-G expression and in its signalization. |
|
| Nonclassical human leukocyte antigen (HLA-G, HLA-E, and HLA-F) in coronary artery disease. |
|
| Soluble HLA-G induces NF-kappaB activation in natural killer cells. |
|
